MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prather, P. L.
Right arrow Articles by Law, P. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prather, P. L.
Right arrow Articles by Law, P. Y.

Interaction of delta-opioid receptors with multiple G proteins: a non- relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins

PL Prather, HH Loh and PY Law

Department of Pharmacology, School of Medicine, University of Minnesota, Minneapolis 55455.

The purpose of the present investigation was to determine whether the coupling of delta-opioid receptors to multiple G proteins in NG108-15 neuroblastoma x glioma cells is a characteristic limited to only this cell line (because of the high density of delta-opioid receptors) and to ascertain whether there is any correlation between delta-opioid agonist potency to inhibit adenylyl cyclase and to activate G proteins. Interactions between receptors and G proteins were investigated using agonist-stimulated incorporation of the photoreactive GTP analog azidoanilido[alpha-32P]GTP ([alpha-32P]AA-GTP) into G protein alpha subunits, with subsequent separation by urea/sodium dodecyl sulfate- polyacrylamide gel electrophoresis. In NG108-15, NS20Y, and N1E115 cell membranes, four alpha subunits (Gi2 alpha, one isoform of Gi3 alpha, and both isoforms of Go alpha) in the 39-41-kDa region were labeled with [alpha-32P]AA-GTP. The delta-opioid agonist [D-Ala2,D-Leu5]- enkephalin (DADLE) produced a dose-dependent, naloxone-reversible increase of [alpha-32P]AA-GTP incorporation into all four alpha subunit subtypes, in all cell lines tested. In addition, with the single exception of Gi3 alpha in NG108-15 cells, the maximal increases in incorporation of the photoaffinity label into all G alpha subunits induced by DADLE were similar. The Bmax values determined for delta- opioid receptors in NG108-15, NS20Y, and N1E115 cell membranes were 570, 370, and 120 fmol/mg of protein, respectively. Finally, although the IC50 values to inhibit intracellular cAMP production and affinity for DADLE were similar across the three cell lines, the EC50 values to produce labeling of the G alpha subunits between cell lines differed by > 100-fold. In fact, only in NS20Y cells were the IC50 and ED50 values comparable. Firstly, these results suggest that simultaneous coupling of the delta-opioid receptor to multiple G protein alpha subunits occurs in a variety of cell lines that express a range of receptor densities. Secondly, the magnitudes with which delta-opioid receptors interact with available G alpha subunits in response to agonist are approximately the same. Finally, there appears to be no relationship between the potency of agonists to inhibit adenylyl cyclase and that required for activation of G proteins.

Volume 45, Issue 5, pp. 997-1003, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. A. Claude-Geppert, J. Liu, J. Solberg, L. J. Erickson-Herbrandson, H. H. Loh, and P.-Y. Law
Antagonist Efficacy in MORS196L Mutant Is Affected by the Interaction between Transmembrane Domains of the Opioid Receptor
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 216 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. D. Alves, K. A. Ciano, V. Boguslavski, E. Varga, Z. Salamon, H. I. Yamamura, V. J. Hruby, and G. Tollin
Selectivity, Cooperativity, and Reciprocity in the Interactions between the {delta}-Opioid Receptor, Its Ligands, and G-proteins
J. Biol. Chem., October 22, 2004; 279(43): 44673 - 44682.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Gomes, A. Gupta, J. Filipovska, H. H. Szeto, J. E. Pintar, and L. A. Devi
A role for heterodimerization of {micro} and {delta} opiate receptors in enhancing morphine analgesia
PNAS, April 6, 2004; 101(14): 5135 - 5139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. D. Alves, Z. Salamon, E. Varga, H. I. Yamamura, G. Tollin, and V. J. Hruby
Direct Observation of G-protein Binding to the Human {delta}-Opioid Receptor Using Plasmon-Waveguide Resonance Spectroscopy
J. Biol. Chem., December 5, 2003; 278(49): 48890 - 48897.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. C. Charles, N. Mostovskaya, K. Asas, C. J. Evans, M. L. Dankovich, and T. G. Hales
Coexpression of delta -Opioid Receptors with {micro} Receptors in GH3 Cells Changes the Functional Response to {micro} Agonists from Inhibitory to Excitatory
Mol. Pharmacol., January 1, 2003; 63(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. A. Martin, M. T. Terruso, and P. L. Prather
Agonist Activity of the delta -Antagonists TIPP and TIPP-psi in Cellular Models Expressing Endogenous or Transfected delta -Opioid Receptors
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 240 - 248.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P. L. Prather, L. Song, E. T. Piros, P. Y. Law, and T. G. Hales
delta -Opioid Receptors Are More Efficiently Coupled to Adenylyl Cyclase Than to L-Type Ca2+ Channels in Transfected Rat Pituitary Cells
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 552 - 562.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. Y. Ho, A. Stadnicka, P. L. Prather, A. R. Buckley, L. L. Current, Z. J. Bosnjak, and W.-M. Kwok
Cannabinoid CB1 Receptor-Mediated Inhibition of Prolactin Release and Signaling Mechanisms in GH4C1 Cells
Endocrinology, May 1, 2000; 141(5): 1675 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. L. Prather, N. A. Martin, C. S. Breivogel, and S. R. Childers
Activation of Cannabinoid Receptors in Rat Brain by WIN 55212-2 Produces Coupling to Multiple G Protein alpha -Subunits with Different Potencies
Mol. Pharmacol., May 1, 2000; 57(5): 1000 - 1010.
[Abstract] [Full Text]


Home page
Protein Eng Des SelHome page
L. Oliveira, A.C.M. Paiva, and G. Vriend
A low resolution model for the interaction of G proteins with G protein-coupled receptors
Protein Eng. Des. Sel., December 1, 1999; 12(12): 1087 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
M. Filizola, L. Laakkonen, and G. H. loew
3D modeling, ligand binding and activation studies of the cloned mouse {delta}, {micro} and {kappa} opioid receptors
Protein Eng. Des. Sel., November 1, 1999; 12(11): 927 - 942.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P.-Y. Law and H. H. Loh
Regulation of Opioid Receptor Activities
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 607 - 624.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Griffin, P. J. Atkinson, V. M. Showalter, B. R. Martin, and M. E. Abood
Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5'-O-(3-[35S]thio)-triphosphate Binding Assay in Rat Cerebellar Membranes
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 553 - 560.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P. G. Szekeres and J. R. Traynor
Delta Opioid Modulation of the Binding of Guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 Cell Membranes: Characterization of Agonist and Inverse Agonist Effects
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1276 - 1284.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Clark, P. J. Emmerson, A. Mansour, H. Akil, J. H. Woods, P. S. Portoghese, A. E. Remmers, and F. Medzihradsky
Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 501 - 510.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Pepe, R.-P. Xiao, C. Hohl, R. Altschuld, and E. G. Lakatta
`Cross Talk' Between Opioid Peptide and Adrenergic Receptor Signaling in Isolated Rat Heart
Circulation, April 15, 1997; 95(8): 2122 - 2129.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Nasman, C. C. Jansson, and K. E.O. Akerman
The Second Intracellular Loop of the alpha 2-Adrenergic Receptors Determines Subtype-specific Coupling to cAMP Production
J. Biol. Chem., April 11, 1997; 272(15): 9703 - 9708.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Martin, Z. Nie, and G. R. Siggins
µ-Opioid Receptors Modulate NMDA Receptor-Mediated Responses in Nucleus Accumbens Neurons
J. Neurosci., January 1, 1997; 17(1): 11 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-H. Chueh, S.-L. Song, and T.-Y. Liu
Heterologous Desensitization of Opioid-stimulated Ca[IMAGE] Increase by Bradykinin or ATP in NG108-15 Cells
J. Biol. Chem., July 14, 1995; 270(28): 16630 - 16637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-G. Liu, M. B. Ruckle, and P. L. Prather
Constitutively Active {micro}-Opioid Receptors Inhibit Adenylyl Cyclase Activity in Intact Cells and Activate G-proteins Differently than the Agonist [D-Ala2,N-MePhe4,Gly-ol5]Enkephalin
J. Biol. Chem., October 5, 2001; 276(41): 37779 - 37786.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics